Navigation Links
MiddleBrook Pharmaceuticals Closes Private Placement of Common Equity Raising $21 Million
Date:1/30/2008

ization of anti-infective drug products that fulfill substantial unmet medical needs in the treatment of infectious disease. The Company is developing anti-infective drugs based on its novel biological finding that bacteria exposed to antibiotics in front- loaded staccato bursts, or "pulses," are killed more efficiently and effectively than those under standard treatment regimens. Based on this finding, MiddleBrook has developed a proprietary, once-a-day pulsatile delivery technology called PULSYS(TM). The Company currently markets the Keflex(R) brand of cephalexin and has received regulatory approval for MOXATAG(TM) -- the first and only once-daily amoxicillin product approved for marketing in the U.S. For more on MiddleBrook, please visit http://www.middlebrookpharma.com.

This announcement contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These statements are based on MiddleBrook's current expectations and assumptions. These statements are not guarantees of future performance and are subject to a number of risks and uncertainties that would cause actual results to differ materially from those anticipated. The words, "believe," "expect," "intend," "anticipate," and variations of such words, and similar expressions identify forward-looking statements, but their absence does not mean that the statement is not forward- looking. Statements in this announcement that are forward-looking include, but are not limited to, statements about the Company's future development plans, clinical trials, potential commercial success, and any financial forecasts included in this announcement.

The actual results realized by MiddleBrook could differ materially from these forward-looking statements, depending in particular upon the risks and uncertainties described in the Company's fil
'/>"/>

SOURCE MiddleBrook Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Sagent Pharmaceuticals, Inc. to Present at Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference
2. Access Pharmaceuticals Announces $2.7 Million New Equity
3. Ferring Pharmaceuticals Announces EUFLEXXA(TM) as Title Sponsor of the National Senior Games Hockey Championships and the GeezerJock of the Year Award
4. Alexion Pharmaceuticals Invites You to Participate in its Fourth Quarter and Full Year 2007 Results Conference Call and Web Cast
5. Cylene Pharmaceuticals Appoints Kenna Anderes, Ph.D. as Vice President of Cancer Biology
6. Onyx Pharmaceuticals to Present at Wachovia Healthcare Conference
7. Arena Pharmaceuticals Announces Initiation of Phase 1 Clinical Trial of Second Generation Niacin Receptor Agonist Under Its Collaboration With Merck & Co., Inc.
8. Angiotech Pharmaceuticals, Inc. - Notice of Conference Call and Webcast
9. VIA Pharmaceuticals Names Rebecca Taub Senior Vice President of Research and Development
10. Anadys Pharmaceuticals to Present at the JPMorgan Healthcare Conference
11. Cerimon Pharmaceuticals Names Matthew J. Meyer its General Counsel and Vice President of Business Development and Licensing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/30/2014)... 30, 2014 Whitehouse Laboratories has formally ... Stability Testing and Package Test Capacity. Responding to growing ... a dramatic increase in environmental chamber storage space that ... and aging samples to be securely held on site ... capital expenditure has already taken place with the recent ...
(Date:10/30/2014)... Isis Pharmaceuticals, Inc. (NASDAQ: ISIS ), ... present a company overview at the Nomura Biotechnology Conference on ... Boston, MA. A live webcast ... Media" section of the Company,s website, www.isispharm.com .  A ... hours and will be archived for a limited time. ...
(Date:10/30/2014)... key challenges in the development of quantum technologies has ... a paper published today (28 October) in Nature ... to make a new type of flexibly designed microscopic ... high-precision sensors and specialised superfast computers, often depend on ... for trapping these tiny particles are hugely problematic because ...
(Date:10/27/2014)... (PRWEB) October 27, 2014 The ... by Type (High & Medium), Sub-type (Primary & ... Processing, Infrastructure & Transportation & Power Generation) - ... the GIS market with analysis and forecasting of ... Market Data Tables with 52 Figures spread through ...
Breaking Biology Technology:Whitehouse Labs Announces Major Capital Investment in Stability and Storage Testing Capacity 2Whitehouse Labs Announces Major Capital Investment in Stability and Storage Testing Capacity 3Isis Pharmaceuticals to Present at the Nomura Biotechnology Conference 2Gas Insulated Switchgear Market worth $21,951.9 Million by 2019 - New Report by MarketsandMarkets 2Gas Insulated Switchgear Market worth $21,951.9 Million by 2019 - New Report by MarketsandMarkets 3Gas Insulated Switchgear Market worth $21,951.9 Million by 2019 - New Report by MarketsandMarkets 4
... 19 /PRNewswire-Asia-FirstCall/ -- China Medical Technologies,Inc. (the "Company") (Nasdaq: ... develops, manufactures and markets advanced in-vitro diagnostic,products, today announced ... analysis system (the "SPR System") from the State Food ... The SPR System utilizes Surface Plasmon Resonance ...
... 16 Cellu Tissue Holdings, Inc. ("Cellu Tissue") today ... with the U.S. Securities and Exchange Commission (the "SEC") relating to ... The offered shares will include shares to be sold by ... company. The total number of shares to be offered, the ...
... Mich., Oct. 16 Forbes Magazine has named Neogen Corporation (Nasdaq: ... Small Companies in America for the eighth time in the last ... of the Great Recession: 42% of the companies in the Russell ... 22% for those in the S&P 500," said Forbes, editors in ...
Cached Biology Technology:China Medical Technologies Announces the SFDA Approval for its SPR System 2China Medical Technologies Announces the SFDA Approval for its SPR System 3Cellu Tissue Holdings, Inc. Files Registration Statement for Proposed Initial Public Offering of Common Stock 2Neogen Again Named to Forbes' List of Best Small Companies 2
(Date:10/31/2014)... 2014 – Dr. John Schoggins , Assistant Professor ... a prestigious New Innovator Award from the National Institutes ... why bats can harbor numerous viruses without becoming sick. ... five years is one of 85 awards given under ... Common Fund. The New Innovator Awards were created to ...
(Date:10/31/2014)... project has developed a new test that can distinguish ... strain of avian influenza virus or "bird flu" with ... a significant step in the fight against this often ... the poultry populations of South East Asia, particularly Indonesia ... its possible transmission to humans and the threat of ...
(Date:10/30/2014)... Arlington bioengineering professor has received a $1.04 million ... regenerate cartilage tissue and reduce osteoarthritis using a ... of microscaffolding made of biodegradable polymers., Liping Tang, ... bioengineering department, said the research is primarily focused ... the battlefield., "We,ve found that if we inject ...
Breaking Biology News(10 mins):UT Southwestern Microbiologist awarded prestigious NIH research grant 2New step towards eradication of H5N1 bird flu 2UTA researcher uses microscaffolding injections to mend cartilage, prevent osteoarthritis 2
... on friends to help get what they need and, according ... University of Wisconsin-Madison, many microbes, plants and animals benefit from ... funded by the National Science Foundation (NSF) and published in ... , describes the complex relationship between a beetle, two types ...
... John S. Dunn Research Foundation has awarded a $3 ... studies in biomedical science that have the potential for ... for Rice researchers whose studies will be conducted at ... on the corner of University Boulevard and Main Street. ...
... Pavlov conditioned his dog to salivate in anticipation of ... to perform certain behaviors when enticed with different smells. ... Chinese University of Hong Kong and the National Institute ... training insects, the interval between the signal, or odor, ...
Cached Biology News:Beetles get by with a little help from their friends 2Moths with a nose for learning 2